Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xue-Fu-Zhu-Yu Capsule for Qi Stagnation and Blood Stasis Syndrome
NCT03091634Phase 2Completed
- Sponsor
- Guang'anmen Hospital
- Start
- May 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Xuefu Zhuyu Jiaonang in Qi stagnation and blood stasis syndrome (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Traditional Chinese Medicine Patient Reported Outcome Scale at 7 weeks. Started May 2017; status: completed.
02
Drugs
Xuefu Zhuyu Jiaonang
03
Conditions
Qi stagnation and blood stasis syndrome
Beyond the preview
Go deeper on NCT03091634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091634.